BioSpace News Archive

Drug Development

Updated RINGSIDE Phase 2 Results Featured in Poster Discussion Session at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, announced further results from the Phase 2 segment of the RINGSIDE study evaluating AL102 in desmoid tumors.

June 5, 2023
·
11 min read
Pharm Country

Intra-Cellular Therapies to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) today announced that it will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 2:00 p.m. PT.

June 5, 2023
·
1 min read
BioMidwest

GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI

GE HealthCare (Nasdaq: GEHC) today announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate image acquisition in magnetic resonance imaging (MRI).

June 5, 2023
·
4 min read
Biotech Bay

Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device

Avinger, Inc. today announced the successful completion of the first clinical cases with the new Tigereye ST image-guided CTO crossing system.

June 5, 2023
·
5 min read
Biotech Beach

Poster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor Platform Presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces today that a poster featuring the Company’s pan-RAS inhibitor program in pancreatic cancer will be presented as part of the Scientific Program at the American Society of Clinical Oncology’s (ASCO) 2023 Annual Meeting held June 2-6, 2023 in Chicago.

June 5, 2023
·
3 min read
Deals

Amedisys Announces Receipt of Unsolicited Proposal From Optum

Amedisys, Inc. announced that on May 26, 2023, the Company received an unsolicited proposal from Optum, a diversified health services company, to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $100 per share.

June 5, 2023
·
10 min read
Deals

CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics

CERo Therapeutics, Inc. (“CERo”) and Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (“PBAX”), a special purpose acquisition company formed for the purpose of acquiring or merging with one or more businesses, today announced they have entered into a definitive business combination agreement.

June 5, 2023
·
15 min read
FDA

Masimo Announces FDA 510(k) Clearance of Radius VSM™

Masimo (NASDAQ: MASI) today announced that Radius VSM™ , a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance.

June 5, 2023
·
12 min read
Business

Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement

Cyclo Therapeutics, Inc. today announced that it has entered into a binding agreement with Rafael Holdings, Inc. (NYSE:RFL) (“Rafael”) under which Rafael has agreed to purchase 4,000,000 shares of common stock of Cyclo Therapeutics.

June 5, 2023
·
5 min read
Business

Datopotamab deruxtecan combinations showed encouraging tumor responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial

Updated results from the TROPION-Lung02 Phase Ib trial showed, with additional enrolment and follow-up from the initial presentation.

June 5, 2023
·
13 min read